All questions on the exam relate to the competencies outlined in "Description of Specialty Practice: Women's Health Physical Therapy."
Based on review of demographic data related to practice settings, the survey frequency data, and the DSP categories, the subject matter expert group used a consensus-building process to develop the examination blueprint.
The blueprint is based on approximately 200 questions in the exam. Questions are written to avoid use of negative stems and may include graphics. Examination questions represent both a practice expectation and a knowledge area associated with that expectation.
A case scenario may have more than one question; however, the questions are written independently so that incorrectly answering one question should not jeopardize answering other questions correctly.
The following is a summary including the percentage of exam questions for each of the major components of the DSP.
A. Foundation Sciences (7%)
B. Clinical Sciences (7%)
C. Behavioral Sciences (6%)
A. Screening (45%)
B. Examination (7%)
C. Evaluation (10%)
D. Diagnosis (8%)
E. Prognosis (6%)
F. Coordination/Communication/Documentation (2%)
G. Procedural Interventions (12%)
H. Outcomes (6%)
A. Communication (3%)
B. Individual and Cultural Differences (2%)
C. Professional Behavior/Professional Development (2%)
D. Critical Inquiry and Clinical Decision-Making/Evidence-Based Practice (8%)
E. Education (2%)
F. Leadership (2%)
G. Social Responsibility and Advocacy (2%)
H. Administration (2%)
I. Consultation (2%)
A. Bowel dysfunction (constipation, fecal incontinence, irritable bowel syndrome) (5%)
B. Lymphedema (5%)
C. Musculoskeletal dysfunction (osteoporosis/fibromyalgia/pelvic girdle/postsurgical dysfunction) (26%)
D. Pelvic floor dysfunction/pain (pelvic organ prolapse, chronic pelvic pain, endometriosis, cystitis) (26%)
E. Pregnancy/postpartum (musculoskeletal dysfunction with pregnancy/postpartum, high-risk pregnancy) (12%)
F. Sexual dysfunction (dyspareunia, vaginismus) (5%)
G. Urinary dysfunction (urinary incontinence, urinary retention, urinary urgency) (15%)
H. Other (cardiovascular and pulmonary, hormone, oncology, autoimmune, neurologic, multiple sclerosis, Parkinson, etc.) (6%)